AXOVANT GENE THERAPIES LTD's ticker is AXGT and the CUSIP is G0750W203. A total of 1 filers reported holding AXOVANT GENE THERAPIES LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,023,000 | -53.5% | 221,444 | -71.6% | 0.00% | -100.0% |
| Q2 2020 | $2,202,000 | +3.6% | 780,916 | -10.3% | 0.00% | 0.0% |
| Q1 2020 | $2,125,000 | +150.6% | 870,771 | +425.8% | 0.00% | – |
| Q4 2019 | $848,000 | -80.0% | 165,601 | -74.8% | 0.00% | -100.0% |
| Q3 2019 | $4,244,000 | +3.3% | 656,887 | -0.3% | 0.00% | 0.0% |
| Q2 2019 | $4,107,000 | – | 659,132 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|